Anixa Biosciences, Inc.
USD2.52
-0.03 (-1.18%)
CEO
Amit Kumar
IPO Date
1983-10-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.56
Prev. Close
$2.55
Day Low
$2.50
Day High
$2.66
52W Low
$2.44
52W High
$5.46
Market Cap
$0.08B
Volume
0.09M
| 25,000 |
| $3.18 |
| 6 Jan 2026 | KUMAR AMIT | director, officer: Chief Executive Officer | A-Award | Acquired | 350,000 | $3.18 |
| 6 Jan 2026 | Gottschalk Emily | director | A-Award | Acquired | 25,000 | $3.18 |
| 6 Jan 2026 | Catelani Michael | President, COO & CFO | A-Award | Acquired | 175,000 | $3.18 |
| 6 Jan 2026 | Baskies Arnold M | director | A-Award | Acquired | 25,000 | $3.18 |
| 16 Dec 2025 | Titterton Lewis H jr | director | M-Exempt | Acquired | 16,000 | $2.92 |
| 16 Dec 2025 | Titterton Lewis H jr | director | M-Exempt | Disposed | 16,000 | $2.92 |
| 31 Oct 2025 | KUMAR AMIT | Chief Executive Officer | M-Exempt | Acquired | 200,000 | $2.92 |
| 31 Oct 2025 | KUMAR AMIT | Chief Executive Officer | F-InKind | Disposed | 169,439 | $4.06 |